Anti-malarials, from China to Africa

Last month, Merrill Goozner linkurl:reported;http://www.the-scientist.com/article/display/36878/ on the success of artemisinin, in combination with other drugs, to treat malaria in Thailand and China. Reuters linkurl:reported;http://www.alertnet.org/thenews/newsdesk/B155919.htm last week that the Li Guoqian, the first person to use artemisinin in a human trial, now wants to use artemisinin to eradicate malaria on the African island nation of Comoros. (Read Goozner's profile of Li's work linkurl:

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Last month, Merrill Goozner linkurl:reported;http://www.the-scientist.com/article/display/36878/ on the success of artemisinin, in combination with other drugs, to treat malaria in Thailand and China. Reuters linkurl:reported;http://www.alertnet.org/thenews/newsdesk/B155919.htm last week that the Li Guoqian, the first person to use artemisinin in a human trial, now wants to use artemisinin to eradicate malaria on the African island nation of Comoros. (Read Goozner's profile of Li's work linkurl:here;http://www.the-scientist.com/2006/12/1/31/1/ .) As has been discussed on ProMEDmail, Li probably gets the life cycle of infected mosquitoes linkurl:wrong;http://www.promedmail.org/pls/promed/f?p=2400:1202:13043317464534780877::NO::F2400_P1202_CHECK_DISPLAY,F2400_P1202_PUB_MAIL_ID:X,35985 (it's 10-14 days, not 30). Commentators also linkurl:point out;http://www.promedmail.org/pls/promed/f?p=2400:1202:13043317464534780877::NO::F2400_P1202_CHECK_DISPLAY,F2400_P1202_PUB_MAIL_ID:X,36007 that it's somewhat unrealistic to expect that you can wipe out malaria in any given area, even if it's an island, because of air and sea travel. But the project certainly has the potential to dramatically lower the disease burden.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies